Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

Neisseria meningitidis lipopolysaccharide (LPS) has adjuvant properties that can be exploited to assist vaccine immunogenicity. The modified penta-acylated LPS retains the adjuvant properties of hexa-acylated LPS but has a reduced toxicity profile. In this study we investigated whether two modified...

Full description

Bibliographic Details
Main Authors:	Ojas H Mehta, Gunnstein Norheim, J Claire Hoe, Christine S Rollier, Jerry C Nagaputra, Katherine Makepeace, Muhammad Saleem, Hannah Chan, David J P Ferguson, Claire Jones, Manish Sadarangani, Derek W Hood, Ian Feavers, Jeremy P Derrick, Andrew J Pollard, E Richard Moxon
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4278719?pdf=render

Similar Items

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on neisseria meningitidis recombinant porA protein: a comparison in mice
by: Mehta, O, et al.
Published: (2014)

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.
by: Nagaputra, J, et al.
Published: (2014)

PorA Variable Regions of Neisseria meningitidis
by: Joanne E. Russell, et al.
Published: (2004-04-01)

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
by: Manish Sadarangani, et al.
Published: (2012-01-01)

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine
by: Sadarangani, M, et al.
Published: (2012)

PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design
by: P Afrough, et al.
Published: (2018-06-01)

Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
by: Moxon, E, et al.
Published: (1998)

Neisseria meningitidis accumulate in large organs during meningococcal sepsis
by: Berit Sletbakk Brusletto, et al.
Published: (2023-11-01)

Primary Meningococcal Arthritis Leading to Neisseria Meningitidies Purpura Fulminans
by: Michael D. Michel, et al.
Published: (2013-03-01)

Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation
by: Sadarangani, M, et al.
Published: (2016)

Mapping the laminin receptor binding domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2.
by: Noha M Abouseada, et al.
Published: (2012-01-01)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
by: Wright, J, et al.
Published: (2004)

Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.
by: Bayliss, C, et al.
Published: (2008)

Clinical cases of meningococcal infection caused by Neisseria meningitidis serogroup W
by: N. V. Skripchenko, et al.
Published: (2019-11-01)

Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial
by: Christine S. Rollier, et al.
Published: (2022-02-01)

Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis.
by: Martin, P, et al.
Published: (2004)

Rare generalized form of meningococcal disease caused by Neisseria meningitidis serogroup W
by: L. N. Mazankova, et al.
Published: (2020-03-01)

The genetic characteristics of Neisseria meningitidis causing invasive meningococcal infections in Smolensk region
by: Mironov K.O., et al.
Published: (2020-05-01)

Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis
by: Philip H. C. Kremer, et al.
Published: (2020-11-01)

Application of capillary electrophoresis- electrospray-mass spectrometry to the separation and characterization of isomeric lipopolysaccharides of Neisseria meningitidis.
by: Li, J, et al.
Published: (2004)

Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
by: Alcides Moniz Munguambe, et al.
Published: (2018-01-01)

Enfermedad por meningococo, Neisseria meningitidis: perspectiva epidemiológica, clínica y preventiva Meningococcal disease caused by Neisseria meningitidis: epidemiological, clinical, and preventive perspectives
by: Lourdes Almeida-González, et al.
Published: (2004-10-01)

Functional significance of factor H binding to Neisseria meningitidis.
by: Schneider, M, et al.
Published: (2006)

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
by: Chang, C-M, et al.
Published: (2022)

Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines
by: Chen Stein-Zamir, et al.
Published: (2019-01-01)

First case of interconnected clusters of primary meningococcal arthritis and meningococcal meningitis due to Neisseria meningitidis serogroup B in Slovenia
by: Miha Simoniti, et al.
Published: (2021-06-01)

Description and nomenclature of Neisseria meningitidis capsule locus
by: Harrison, O, et al.
Published: (2013)

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
by: Awanye, A, et al.
Published: (2019)

Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay.
by: Peiser, L, et al.
Published: (2006)

Obstetric and Neonatal Invasive Meningococcal Disease Caused by Neisseria meningitidis Serogroup W, Western Australia, Australia
by: Julie Hart, et al.
Published: (2024-02-01)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
by: Shamez Ladhani, et al.
Published: (2016-02-01)

Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58.
by: Saunders, N, et al.
Published: (2000)

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial
by: Rollier, CS, et al.
Published: (2022)

Description and Nomenclature of Neisseria meningitidis Capsule Locus
by: Odile B. Harrison, et al.
Published: (2013-04-01)

An Overview of Neisseria meningitidis
by: Hollingshead, S, et al.
Published: (2019)

Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein.
by: Declan T Bradley, et al.
Published: (2015-01-01)

Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis.
by: Mackinnon, F, et al.
Published: (2002)

Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.
by: Hoang, L, et al.
Published: (2005)

A case report of primary meningococcal pericarditis secondary to Neisseria meningitidis in a young female patient
by: Matthew Green, et al.
Published: (2022-01-01)